Cargando…

Targeting melanoma residual disease by USP7

Detalles Bibliográficos
Autores principales:	Vishnoi, Monika, Marchetti, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331028/ https://www.ncbi.nlm.nih.gov/pubmed/30680060 http://dx.doi.org/10.18632/oncotarget.26497

Ejemplares similares

USP8 mutation in Cushing's disease
por: Huang, Chuanxin, et al.
Publicado: (2015)

USP7 substrates identified by proteomics analysis reveal the specificity of USP7
por: Nie, Litong, et al.
Publicado: (2022)

Identification and Characterization of USP7 Targets in Cancer Cells
por: Georges, Anna, et al.
Publicado: (2018)

USP7: Novel Drug Target in Cancer Therapy
por: Wang, Zhiru, et al.
Publicado: (2019)

Minimal residual disease in pediatric ALL
por: Pui, Ching-Hon, et al.
Publicado: (2017)

Pharmacological inhibition of USP7 suppresses growth and metastasis of melanoma cells in vitro and in vivo
por: Xiang, Minmin, et al.
Publicado: (2021)

On the way to specifically targeting minimal residual disease?
por: Gebauer, Gerhard
Publicado: (2008)

Selective Inhibition of USP7
por: Menard, Robert, et al.
Publicado: (2012)

EPEN-03. USP7 is an interaction partner of EZHIP and potential druggable target in PFA ependymomas
por: Jenseit, Anne, et al.
Publicado: (2022)

The therapeutic potential of targeting minimal residual disease in melanoma
por: Patel, Riyaben P, et al.
Publicado: (2023)

USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation
por: Palazón‐Riquelme, Pablo, et al.
Publicado: (2018)

Author Correction: Identification and Characterization of USP7 Targets in Cancer Cells
por: Georges, Anna, et al.
Publicado: (2019)

Neuroinflammation inhibition by small-molecule targeting USP7 noncatalytic domain for neurodegenerative disease therapy
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Targeted Therapies for Melanoma
por: Smetana, Karel, et al.
Publicado: (2020)

Regulation of USP7/HAUSP in response to DNA damage: Yet another role for ATM
por: Khoronenkova, Svetlana V., et al.
Publicado: (2012)

Targeting USP-7 by a Novel Fluorinated 5-Pyrazolyl-Urea Derivative
por: Morretta, Elva, et al.
Publicado: (2023)

Crystal Structure of USP7 Ubiquitin-like Domains with an ICP0 Peptide Reveals a Novel Mechanism Used by Viral and Cellular Proteins to Target USP7
por: Pfoh, Roland, et al.
Publicado: (2015)

Molecular mechanism for the substrate recognition of USP7
por: Cheng, Jingdong, et al.
Publicado: (2015)

Fbw7 and Usp28 – enemies and allies
por: Taranets, Lyudmyla, et al.
Publicado: (2015)

Highlights in USP7 inhibitors for cancer treatment
por: Oliveira, Rita I., et al.
Publicado: (2022)

USP27X, a new player on EMT and fibroblast activation
por: Díaz, Víctor M.
Publicado: (2018)

Novel Therapeutic Targets in Melanoma
por: Cerezo, Michaël, et al.
Publicado: (2023)

USP8 is a Novel Therapeutic Target in Melanoma Through Regulating Receptor Tyrosine Kinase Levels
por: Duan, Baoxue, et al.
Publicado: (2021)

Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases
por: Bhattacharya, Seemana, et al.
Publicado: (2018)

CDDO-Me reveals USP7 as a novel target in ovarian cancer cells
por: Qin, Dongjun, et al.
Publicado: (2016)

The isolation and characterization of CTC subsets related to breast cancer dormancy
por: Vishnoi, Monika, et al.
Publicado: (2015)

The identification of a TNBC liver metastasis gene signature by sequential CTC‐xenograft modeling
por: Vishnoi, Monika, et al.
Publicado: (2019)

TIP60 governs the auto-ubiquitination of UHRF1 through USP7 dissociation from the UHRF1/USP7 complex
por: Ahmad, Tanveer, et al.
Publicado: (2021)

Up‐regulated deubiquitinase USP4 plays an oncogenic role in melanoma
por: Guo, Weinan, et al.
Publicado: (2018)

Deubiquitinase USP19 extends the residual enzymatic activity of phenylalanine hydroxylase variants
por: Sarodaya, Neha, et al.
Publicado: (2022)

USP35 is a Potential Immunosuppressive Factor in Skin Cutaneous Melanoma
por: Zhang, Qian, et al.
Publicado: (2022)

Targeting Ubiquitin-Specific Protease 7 (USP7) in Cancer: A New Insight to Overcome Drug Resistance
por: Lu, Jiabin, et al.
Publicado: (2021)

USP7 Is a Master Regulator of Genome Stability
por: Valles, Gabrielle J., et al.
Publicado: (2020)

Kinetic analysis of multistep USP7 mechanism shows critical role for target protein in activity
por: Kim, Robbert Q., et al.
Publicado: (2019)

Application of liquid biopsy for prognostic status of cancers and drug response
por: Marchetti, Dario
Publicado: (2020)

Targeted treatment of advanced NRAS-mutated melanoma
por: Koelblinger, Peter, et al.
Publicado: (2017)

Downregulation of SOX2 by inhibition of Usp9X induces apoptosis in melanoma
por: Potu, Harish, et al.
Publicado: (2021)

USP22 promotes melanoma and BRAF inhibitor resistance via YAP stabilization
por: Wei, Ying, et al.
Publicado: (2021)

The regulation of NONO by USP11 via deubiquitination is linked to the proliferation of melanoma cells
por: Feng, Peifu, et al.
Publicado: (2020)

Evolution of the highly networked deubiquitinating enzymes USP4, USP15, and USP11
por: Vlasschaert, Caitlyn, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gnam0mtg1bb0n9sldr4djd49d8